- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 194
Passage Bio packs in another $110m
Lilly Asia Ventures returned to take part in a series B round led by Access Industries unit Access Biotechnology that took Passage Bio's funding to $226m to date.
Sep 5, 2019Oct locks in series B funding
The construction organisation platform added funding from Salesforce Ventures, Globis Capital Partners and four regional banks to close the round at $22.6m.
Sep 5, 2019Kasisto caps series B at $32m
Propel Venture Partners helped add $15m to the conversational AI developer's latest round, having contributed to the first tranche alongside Mastercard.
Sep 4, 2019Gyroscope spins to series B round
Gyroscope Therapeutics, a dry AMD treatment developer exploiting University of Cambridge research, has secured $61.2m from cornerstone investors Cambridge Innovation Capital and Syncona.
Sep 4, 2019Guiji Zhineng gets series B-plus cash
The Tencent-backed enterprise automation technology supplier has raised hundreds of millions of renminbi in a round led by CMB Telecom.
Sep 4, 2019Tongcheng Life takes in $100m
Legend Capital led a $100m round for social commerce platform Tongcheng Life that also featured existing backer Bertelsmann Asia Investments.
Sep 4, 2019VIPThink invites New Oriental to series B round
The mathematics learning platform has raised a nine-figure renminbi amount in a New Oriental-led round that included Ximalaya FM.
Sep 4, 2019Investors slip $23m to Elliptic
SBI Group and Santander InnoVentures backed a series B round that boosted cryptocurrency security tool developer Elliptic's funding to $30m altogether.
Sep 4, 2019Achilles Therapeutics accesses $120m
UCL and Francis Crick-founded Achilles has raised series B funding at a reported $228m valuation and will now look to advance lung cancer and melanoma treatments.
Sep 3, 2019Homee zeroes in on $15m
The home services platform increased its overall funding to nearly $30m in a series B round that included Ferguson Enterprises, Liberty Mutual, The Hartford and State Farm.
Sep 3, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


